LENZ Therapeutics, Inc. (LENZ)
4.59
-0.09
(-1.92%)
USD |
NASDAQ |
Aug 24, 16:00
4.60
+0.01
(+0.22%)
After-Hours: 20:00
LENZ Therapeutics Profit Margin (Quarterly) : -581.8% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -581.8% |
| March 31, 2026 | -2.18K% |
| December 31, 2025 | -2.26K% |
| Date | Value |
|---|---|
| September 30, 2025 | -133.6% |
| June 30, 2025 | -298.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -584.5% |
| Enveric Biosciences, Inc. | -- |
| Liquidia Corp. | 43.52% |
| Aquestive Therapeutics, Inc. | -165.5% |
| Impact BioMedical, Inc. | -23.33K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.77% |
| Return on Assets | -50.68% |
| Return on Invested Capital | -54.57% |
| Gross Profit Margin (Quarterly) | 94.90% |
| Operating Margin (Quarterly) | -622.9% |
| Return on Net Operating Assets | -2.11K% |